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RESEARCH COMMUNICATION

Ubiquitin ligase MKRN1
modulates telomere length
homeostasis through
a proteolysis of hTERT

Telomere homeostasis is regulated by telomerase and a
collection of associated proteins. Telomerase is, in turn,
regulated by post-translational modifications of the ratelimiting catalytic subunit hTERT. Here we show that
disruption of Hsp90 by geldanamycin promotes efficient
ubiquitination and proteasome-mediated degradation of
hTERT. Furthermore, we have used the yeast two-hybrid
method to identify a novel RING finger gene (MKRN1)
encoding an E3 ligase that mediates ubiquitination of
hTERT. Overexpression of MKRN1 in telomerase-positive cells promotes the degradation of hTERT and decreases telomerase activity and subsequently telomere
length. Our data suggest that MKRN1 plays an important role in modulating telomere length homeostasis
through a dynamic balance involving hTERT protein stability.

composed of a catalytic subunit, hTERT, and its template RNA, hTR (Blackburn 1992).
Telomerase activity correlates with hTERT expression, implicating this catalytic subunit as the rate-limiting component of the telomerase holoenzyme (Nakamura and Cech 1998). Although telomerase activity is
regulated by hTERT gene expression (Wang et al. 1998),
several lines of evidence have suggested a post-translational regulation of telomerase activity. Post-translational modifications of telomerase may involve the interaction of hTERT with accessory proteins, chaperones,
and polypeptide modifiers (Zhou and Lu 2001; G.E. Lee
et al. 2004). For example, the molecular chaperone
Hsp90 binds specifically to hTERT to promote the assembly of active telomerase both in a cell-free system
and in intact cells (Holt et al. 1999). Moreover, inhibiting
Hsp90 blocks the assembly of active telomerase, although the underlying mechanism is not fully elucidated.
In this present study, we report that disruption of
Hsp90 function by geldanamycin (GA) promotes ubiquitination and proteasome-mediated degradation of hTERT.
Furthermore, we have identified a novel hTERT-binding
protein, Makorin RING finger protein 1 (encoded by the
MKRN1 gene, a member of an ancient gene family) that
functions as an E3 ligase and mediates ubiquitination of
hTERT (Gray et al. 2000). Overexpression of MKRN1 in
telomerase-positive cells decreases telomerase activity
and telomere length. These observations suggest that
MKRN-1, a post-translational modifier of hTERT, plays
a negative role in telomere length homeostasis. These
studies also define for the first time a physiological function associated with the very well-conserved Makorin
gene family.

Received December 13, 2004; revised version accepted
February 15, 2005.

Results and Discussion

Jun Hyun Kim,1,2 Sun-Mi Park,1 Mi Ran Kang,1,2
Sue-Young Oh,1,2 Tae H. Lee,1 Mark T. Muller,3
and In Kwon Chung1,2,4
1
Department of Biology and 2Molecular Aging Research
Center, Yonsei University, Seoul 120-749, Korea;
3
Department of Molecular Biology and Microbiology,
University of Central Florida, Orlando, Florida, 32826, USA

Telomeres are essential and functional components of
the physical ends of eukaryotic chromosomes (Greider
1996). Properly capped telomeres enable cells to distinguish chromosome ends from double-strand breaks in
the genome. Without functional telomeres, chromosomes are prone to nucleolytic degradation and end-toend fusion leading to cell death or possibly genetic recombination and survivor selection (Blasco et al. 1997).
Most normal human somatic cells show a progressive
loss of telomeric DNA during successive rounds of cell
division due to a DNA end replication problem (Lingner
et al. 1995). Thus, telomere shortening has been proposed as a ticketing mechanism that controls the replicative capacity of cells and cellular senescence (Harley
1991). Cells with extended replicative life spans have
mechanisms to counteract loss of telomeric DNA. In
most human cancer cells, telomere shortening is alleviated by telomerase, a ribonucleoprotein enzyme that is
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hTERT is sensitive to the Hsp90
antagonist geldanamycin
Inhibition of Hsp90 function by GA prevents the assembly of active telomerase (Holt et al. 1999). Because GA
mediates the dissociation of Hsp90 from its client proteins and promotes rapid degradation by the proteasome
(Goetz et al. 2003), we predicted that hTERT would be
sensitive to the Hsp90 antagonist. To investigate this
possibility, we transfected H1299 cells with Flag-tagged
hTERT and assessed protein levels in the absence or
presence of GA. hTERT protein was highly expressed in
untreated cells but was down-regulated in a time-dependent manner in response to GA treatment, with >50% of
the protein being eliminated within 2 h of treatment
(Fig. 1A, lanes 1–5 in upper blot). TRF1 expression levels
were not affected by GA treatment (Fig. 1A, middle blot).
GA also decreased the level of hTERT expression in a
dose-dependent manner (Fig. 1B). To verify the ability of
GA to down-regulate endogenous hTERT levels, H1299
cells were treated with GA and immunoblotted using a
polyclonal anti-hTERT antibody. Treatment of cells
with GA significantly decreased endogenous hTERT levels (Fig. 1C, upper blot).
Because the Hsp90 chaperone complex binds to
hTERT and influences proper assembly with hTR to
form an active enzyme (Holt et al. 1999; Forsythe et al.
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Figure 1. hTERT is sensitive to the Hsp90 antagonist geldanamycin. (A) Down-regulation of ectopically expressed hTERT by GA.
H1299 cells transfected with Flag-hTERT or Flag-TRF1 were treated
with 0.1 µM GA for the indicated times. Lysates were resolved on
8% SDS-PAGE and analyzed by immunoblotting using an anti-Flag
antibody probe. Cells were pretreated with 10 µM MG132 or E-64
for 2 h, either alone or before treatment with GA. (B) Concentration
dependence of GA on hTERT. H1299 cells transfected with FlaghTERT or hTERT-HA were treated for 2 h with the GA concentration indicated. The hTERT proteins were visualized with anti-Flag
or anti-HA antibodies as marked by each blot. (C) Down-regulation
of endogenous hTERT by GA. H1299 cells were treated with 0.1 µM
GA for the indicated times, and cell lysates were analyzed by immunoprecipitation with anti-hTERT antibody followed by immunoblotting using the same antibody probe. Cells were pretreated
with 10 µM MG132 for 2 h, either alone or before treatment with
GA. Molecular weight markers are shown in kilodaltons. (D) H1299
cells were treated with 0.1 µM GA for the indicated times, and cell
lysates were analyzed for telomerase activity by the TRAP assay.
The lane labeled LB corresponds to the negative control (lysis buffer
only). ITAS represents the internal telomerase assay standard. (E)
Saos-2 cells transfected with Flag-hTERT or hTERT-HA or empty
vector were untreated or treated with 0.1 µM GA for 16 h, and cell
lysates were analyzed for telomerase activity.

2001), we tested the influence of GA-induced degradation of hTERT on telomerase activity in H1299 cells.
Incubation with GA reduced telomerase activity in a
time-dependent manner (Fig. 1D). To more clearly determine the effects of GA on telomerase activity, N-terminal Flag-tagged hTERT and C-terminal HA-tagged
hTERT constructs were transfected to Saos-2 cells (these
cells lack detectable telomerase activity) (Kim et al.
2003). The forced expression of exogenous hTERT produced detectable telomerase activity in these cells (Fig.
1E). Furthermore, incubation with GA reduced telomerase activity to near basal levels. These results suggest
that Hsp90 is not only important for the proper conformation of hTERT but also for maintaining telomerase
assembly.
hTERT is ubiquitinated and degraded via
the proteasomal pathway
Reduction in hTERT levels could be due to degradation
and/or turnover of the protein. To examine whether the
GA-mediated degradation of hTERT proceeds via the
proteasome, we pretreated H1299 cells for 2 h with the
specific proteasome inhibitor MG132, and subsequently
incubated with GA for 4 h. Incubation of cells with
MG132 rescued the GA-induced down-regulation of
hTERT (Fig. 1A, lane 6 in upper blot), whereas pretreatment of cells with the lysosomal proteolysis inhibitor

E-64 had no effect on hTERT levels (Fig. 1A, cf. lanes 6
and 7). In the absence of GA treatment, incubation of
cells with either MG132 or E-64 alone did not cause a
significant change in the levels of hTERT expression
relative to untreated controls (Fig. 1A, lanes 8,9 in upper
blot). These results indicate that GA-induced downregulation of hTERT is due to proteasome-mediated degradation. Note that endogenous hTERT levels were similarly affected. Specifically, pretreating cells with MG132
followed by GA, reversed the degradation of endogenous
hTERT protein (Fig. 1C, cf. upper and lower blots).
GA-mediated protein degradation by the proteasome
depends on conjugation of ubiquitin to the Hsp90 client
protein (Isaacs et al. 2002). To determine whether
hTERT is ubiquitinated in vivo prior to its degradation,
H1299 cells cotransfected with Flag-tagged hTERT and
HA-tagged ubiquitin constructs were treated with GA,
ALLnN (a general proteasome inhibitor), or both. The
immunoprecipitated products were evaluated by immunoblotting with selected probes as described in the legend for Figure 2. Treatment of GA alone decreased
hTERT levels and GA plus ALLnN reversed this trend
(Fig. 2A, cf. lanes 3 and 4 in upper blot). Treatment with
ALLnN alone did not affect hTERT levels relative to
controls (Fig. 2A, cf. lanes 1 and 2 in upper blot). Note
that the amount of high-molecular-weight smearing was
much greater in the ALLnN-treated cells (Fig. 2A, cf.
lanes 1,3 and 2,4 in upper blot). To confirm that these
slower migrating bands represented ubiquitinated
hTERT, anti-Flag immunoprecipitates were probed with
anti-HA antibody to illuminate ubiquitin-modified
hTERT (Fig. 2A, lower blot). Again, ubiquitinated
hTERT was dramatically elevated in the presence of the
proteasome inhibitor ALLnN (Fig. 2A, cf. lanes 1,3 and
2,4 in lower blot). These high-molecular-weight smears
are diagnostic for polyubiquitinated proteins (Girnita et
al. 2003). This modification was substantially enhanced
by the treating cells with both ALLnN and GA (Fig. 2A,
cf. lanes 2 and 4 in lower blot). In addition, hTERT displayed enhanced GA-induced ubiquitination in a dosedependent manner in the presence of MG132 (Fig. 2B).

Figure 2. hTERT is ubiquitinated prior to proteasome-mediated
degradation. (A) H1299 cells were cotransfected with Flag-hTERT
and HA-ubiquitin. Cells were either untreated or treated for 2 h with
10 µg/mL ALLnN or 0.1 µM GA, or a combination of the two as
specified. Immunoprecipitation was performed with anti-Flag antibody before probing with anti-hTERT or anti-HA antibodies as indicated. Molecular weight markers are shown in kilodaltons. (B)
H1299 cells cotransfected with Flag-hTERT and HA-ubiquitin were
treated for 1 h with the GA concentration indicated in the presence
of 10 µM MG132. (C) H1299 cells cotransfected with Flag-hTERT
and HA-ubiquitin were either untreated or treated for 2 h with 10
µg/mL ALLnN as specified. Proteins were immunoprecipitated with
anti-Flag antibody followed by immunoblotting using an anti-HA
antibody probe.
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These data indicate that hTERT is ubiquitinated in GAtreated cells prior to proteasome-dependent degradation
in a manner similar to other Hsp90 client proteins
(Isaacs et al. 2002). On the basis of these results, we
propose that two counteracting processes mediate
hTERT levels: proteasomal degradation by the ubiquitination pathway and rescue (or protection) from degradation by Hsp90. The dynamic balance between these two
processes determines equilibrium levels of hTERT,
which then sets cellular telomerase activity. It is also
worth noting that polyubiquitinated hTERT forms were
significantly elevated by ALLnN in the absence of GA
treatment (Fig. 2C, lanes 5,6). These results suggest that
hTERT is subject to ubiquitination even in the absence
of GA.
Identification of a RING finger protein that interacts
with hTERT
Ubiquitination is carried out by a cascade of reactions
catalyzed by ubiquitin-activating enzyme (E1), ubiquitin-conjugating enzyme (E2), and ubiquitin ligase (E3)
(Pickart 2001). E3 proteins are known to play a pivotal
role in determining the specificity of the system by recognizing target substrates. We therefore established a
yeast two-hybrid system to search for an E3 ligase involved in hTERT degradation. With the C-terminal domain of hTERT as bait (residues 946–1132), we identified
proteins that interact with hTERT (Fig. 3A). One of the
isolated clones contains a C3HC4-type RING finger domain that is present in many E3 ubiquitin ligases
(Joazeiro et al. 1999). We discovered that the protein was
identical to Makorin RING finger protein 1 (MKRN1)
(Gray et al. 2000). MKRN1 is uniformly expressed in all
tissues and encodes a putative ribonucleoprotein with a
distinctive array of zinc-finger motifs, including four
C3H zinc-finger motifs, an unusual Cys-His motif, and a
highly conserved RING finger domain (Fig. 3B). MKRN1
orthologs have been identified in a wide spectrum of species (from invertebrates to vertebrates), suggesting an ancient origin of this highly conserved gene (Gray et al.
2000).
The physical interaction between MKRN1 and hTERT
was examined by coimmunoprecipitation experiments
in cells cotransfected with C-terminal HA-tagged
hTERT and MKRN1-V5 expression vectors (Fig. 3C). The
data show that MKRN1 was barely detectable in lysates
directly probed with anti-V5 antibody (Fig. 3C, lanes 1,3).
This suggests that MKRN1 may be rapidly degraded
through auto-ubiquitination like other RING finger proteins that promote their own ubiquitination/degradation (Joazeiro and Weissman 2000). In the presence of
ALLnN, however, there was a significant increase in
both unmodified and ubiquitinated MKRN1 species (Fig.
3C, lanes 2,4). Immunoprecipitation of cell lysates with
anti-HA antibody (hTERT) and subsequent immunoblot
analysis with anti-V5 antibody (MKRN1) revealed that
hTERT coimmunoprecipitated with MKRN1 in cells
treated with ALLnN but not in negative drug control
cells (Fig. 3C, cf. lanes 7 and 8), suggesting that hTERT
binds to MKRN1 in mammalian cells. When this experiment was modified using N-terminal Flag-tagged hTERT
and MKRN1-V5 expression vectors with a different proteasome inhibitor (MG132), essentially identical results
were obtained (Fig. 3D).
778
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Figure 3. MKRN1 interacts with hTERT. (A) Analysis of the physical interaction between hTERT and MKRN1 using the yeast twohybrid assay. Five domains of hTERT were analyzed for binding to
MKRN1. TRF1 bait was used as a negative control. Blue signal on
the SG-HWU/X plate indicates activation of the reporter gene LacZ.
(S) Synthetic; (G) galactose; (H) histidine (−); (W) tryptophan (−); (U)
uracil (−); (X) X-gal. (B) Schematic diagram of MKRN1 domains.
Amino acid sequences surrounding the RING finger domain in
MKRN1 and mutants used in this study. Cysteines and a histidine
in the RING finger domain are shown in red. The mutated residue
in MKRN1H307E is shown in blue. (C) H1299 cells cotransfected with
hTERT-HA and MKRN1-V5 were either untreated or treated for 2 h
with 10 µg/mL ALLnN. Anti-HA immunoprecipitates were analyzed by immunoblotting using an anti-V5 antibody probe. The left
panel shows the immunoblot of cell lysates (3% of the precipitated
lysates) probed with anti-V5 antibody. hTERT-HA was visualized
with an anti-HA antibody probe. (D) H1299 cells cotransfected with
Flag-hTERT and MKRN1-V5 were either untreated or treated for 2 h
with 10 µM MG132. Anti-Flag immunoprecipitates were analyzed
by immunoblotting using an anti-V5 antibody probe. The left panel
shows the immunoblot of cell lysates (3% of the precipitated lysates) probed with anti-V5 antibody. Flag-hTERT was visualized
with an anti-Flag antibody probe.

MKRN1 is an E3 ubiquitin-ligase that enhances
ubiquitination of hTERT
We next investigated the involvement of MKRN1 in
ubiquitination of hTERT. In vitro ubiquitination assays
using purified components showed that the C-terminal
domain (residues 946–1132) of hTERT was efficiently
ubiquitinated by wild-type MKRN1, but not by mutants
MKRN1H307E or MKRN1⌬C (Fig. 4A). Thus, while
MKRN1 is an E3 ligase for hTERT, mutating the RING
finger domain destroys this activity in vitro, indicating
that the RING finger domain is indispensable for E3
activity.
To investigate whether MKRN1 contributes to the
ubiquitination of hTERT in vivo, H1299 cells were cotransfected with Flag-hTERT, HA-ubiquitin, and
MKRN1-V5 constructs, and immunoprecipitated with
anti-Flag antibody followed by immunoblotting with
anti-HA antibody. Ubiquitin conjugates of hTERT were
easily detected in the presence of MG132 (Fig. 4B, lane 2
in upper blot). The amount of ubiquitinated hTERT was
significantly reduced in cells cotransfected with MKRN1
plus MKRN1H307E (Fig. 4B, lane 6) compared to cells
transfected with MKRN1 alone (Fig. 4B, lane 2) or in
cells cotransfected with MKRN1 plus MKRN1⌬C (Fig.
4B, lane 4). These data demonstrate that mutating the
RING finger in MKRN1H307E does not impair its ability
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7–12 in lower blot). On the basis of these data, we conclude that MKRN1 is an E3 ligase for hTERT ubiquitination in mammalian cells. Although our findings show
that MKRN1 associates with and efficiently ubiquitinates hTERT, our data do not exclude the existence of
other E3 ligases that target hTERT. The Hsp90/Hsp70associated U-box ubiquitin ligase CHIP (C terminus
Hsc70-interacting protein) may mediate the GA-stimulated degradation of some Hsp90 client proteins (Connell
et al. 2001). Whether CHIP E3 activity regulates in vivo
stability of hTERT remains to be elucidated. We are presently investigating the roles of CHIP and other E3 ligases
in the GA-induced as well as the constitutive ubiquitination of hTERT.
Overexpression of MKRN1 decreased telomerase
activity and telomere length
Figure 4. MKRN1 functions as an E3 ubiquitin-ligase for hTERT in
vitro and in vivo. (A) HA-tagged hTERT (residues 946–1132) was
incubated with MKRN1 or mutants in the presence of E1, E2, and
His6-ubiquitin. Samples were resolved by 6% SDS-PAGE and analyzed by immunoblotting with an anti-HA antibody probe. (B)
H1299 cells were cotransfected with Flag-hTERT, HA-ubiquitin,
MKRN1-V5, and together with either MKRN1H307E-V5 or
MKRN1⌬C-V5 as specified. Cells were untreated or treated with 10
µM MG132 for 2 h. Anti-Flag immunoprecipitates and cell lysates
were analyzed by immunoblotting with anti-HA antibody and antiV5 antibody probes, respectively. (C) H1299 cells cotransfected with
Flag-hTERT and HA-ubiquitin, and together with or without
MKRN1-V5 as indicated, were treated with 10 µM MG132 for the
indicated times. Anti-Flag immunoprecipitates and cell lysates were
analyzed by immunoblotting with anti-HA antibody and anti-V5
antibody probes, respectively.

to interact with hTERT but disrupts the domain structure of the ubiquitin ligase activity, thereby yielding a
dominant-negative phenotype. When the levels of ectopically expressed MKRN1 and mutants were examined, MKRN1 expression was clearly elevated by MG132
treatment (Fig. 4B, cf. lanes 1 and 2 in lower blot). In
contrast, MG132 had no effect on the amount of
MKRN1⌬C (Fig. 4B, cf. lanes 3 and 4), suggesting that the
deleted C-terminal region is required for auto-ubiquitination of MKRN1. When both MKRN1 and MKRN1H307E
were cotransfected, we were able to detect MKRN1H307E
in the absence of MG132 although the expression level
was slightly less (approximately twofold) compared with
that elicited by the MG132 treatment (Fig. 4B, cf. lanes 5
and 6). Thus, mutating the histidine residue in the RING
finger motif inhibits auto-ubiquitination.
To examine the in vivo role of MKRN1 in ubiquitination of hTERT, we cotransfected H1299 cells with FlaghTERT plus HA-ubiquitin and immunoprecipitated
with anti-Flag antibody followed by immunoblotting
with anti-HA antibody. Although no hTERT-ubiquitin
conjugates were observed in untreated cells (Fig. 4C, lane
1 in upper blot), low levels were detected after 45–60 min
of MG132 treatment (Fig. 4C, lanes 5,6). In marked contrast, coexpression of MKRN1 caused a clear and dramatic increase in the amount of ubiquitinated hTERT
species (Fig. 4C, lanes 7–12). When the expression levels
of MKRN1 were examined by immunoblotting with
anti-V5 antibody, both unmodified and polyubiquitinated MKRN1 species increased in a time-dependent
manner in response to MG132 treatment (Fig. 4C, lanes

Because MKRN1 functions as an E3 ligase for hTERT
ubiquitination in vivo, we examined whether ectopic expression of MKRN1 affects telomerase activity. We established HT1080 cell lines stably expressing MKRN1
(or an empty vector negative control). Levels of ectopically expressed MKRN1 were examined by immunoblotting with anti-V5 antibody (Fig. 5A). Treatment of
MG132 resulted in a substantial increase in MKRN1
compared to untreated cells (Fig. 5A, cf. lanes 3 and 6).
Cells expressing MKRN1 and the empty vector grew normally and exhibited no detectable differences in growth

Figure 5. Overexpression of MKRN1 decreases telomerase activity
and telomere length. (A) HT1080 cells were stably transfected with
MKRN1-V5 or an empty vector. The cells were untreated or treated
for 2 h with 10 µM MG132. Cell lysates were analyzed by immunoblotting with anti-V5 antibody probe. (B) Stable HT1080 cell lines
(MKRN1 and vector) were harvested at 45 PD, and telomerase activities were measured with different amounts of proteins using the
TRAP assay. (C) Cell lysates from stable HT1080 cell lines were
analyzed by immunoprecipitation with anti-hTERT antibody followed by immunoblotting using the same antibody probe. (D) Representative results of RT–PCR analysis for the expression of
MKRN1, hTERT, and hTR in stable HT1080 cell lines. RT–PCR
products from each sample were normalized to glyceraldehyde-3phosphate dehydrogenase (GAPDH) signal. (E) Stable HT1080 cell
lines were harvested at 45 PD, and genomic DNA was digested with
RsaI and HinfI, followed by Southern blotting using a telomere repeat probe.
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rates or morphology over 45 population doublings (PD).
At 45 PD, we compared telomerase activity in stable cell
lines expressing MKRN1 and the empty vector. Telomerase activity in cells expressing MKRN1 was significantly decreased relative to the control cell line (Fig. 5B).
The overexpression of MKRN1 resulted in a down-regulation of the endogenous hTERT protein (Fig. 5C). These
results suggest that MKRN1 acts as a negative regulator
of telomerase. However, it is not clear whether this decrease is due to a MKRN1-related decrease in the expression of hTERT or hTR genes. To address this possibility,
the impact of MKRN1 on gene expression of hTERT and
hTR was evaluated using RT–PCR analysis (J.H. Kim et
al. 2002). Whereas the MKRN1 mRNA level was much
higher in cells expressing the gene (relative to control
cells), we observed no significant differences in steadystate levels of hTERT mRNA or hTR transcripts in cell
lines expressing MKRN1 and the empty vector (Fig. 5D).
To examine whether the MKRN1-mediated decrease in
telomerase activity was attended by changes in telomere
lengths, we performed a terminal restriction fragment
(TRF) size analysis (G.E. Lee et al. 2004). Control cells
exhibited an average telomere length of ∼6 kb with most
fragments spread over a range of ∼5 to 7 kb (Fig. 5E).
Telomeres were clearly shortened in the clones expressing MKRN1 with a decrease in TRF length to ∼4 kb and
spanning down to roughly 2.5 kb. These findings suggest
that MKRN1 exerts a negative role in telomere length
maintenance and/or regulation.
The data presented here demonstrate that MKRN1
markedly enhances hTERT ubiquitination in the absence of GA treatment. This suggests that MKRN1 functions as an E3 ligase for the constitutive ubiquitination
of mature hTERT assembled with hTR in the nucleus
when the molecular chaperone Hsp90 is intact. Additionally, MKRN1 may perform this same function with
newly synthesized hTERT in cytoplasm. Ubiquitination
of hTERT could be regulated by changes in the expression and activity of MKRN1 and de-ubiquitinating enzymes. Moreover, continued expression of MKRN1 in
telomerase-positive cells resulted in a decrease in telomerase activity and cells with shortened telomeres. Thus,
MKRN1 regulates telomerase activity and telomere
length through dynamic control of hTERT protein stability. The function of telomerase during development,
aging, and cancer has been extensively studied (S.H. Kim
et al. 2002). MKRN1, a post-translational modifier of
hTERT, may play an important role in telomere length
maintenance and/or regulation through ubiquitin-mediated proteolysis of hTERT.
Materials and methods
Cell lines and culture conditions
The human lung carcinoma cell line H1299 was cultured in RPMI-1640
medium, and the human fibrosarcoma cell line HT1080 was cultured in
Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum, 100 units/mL penicillin, and 100 µg/mL streptomycin in 5%
CO2 at 37°C. The human osteosarcoma cell line Saos-2 was maintained
in McCoy’s 5A medium containing 15% fetal bovine serum, 100 units/
mL penicillin, and 100 µg/mL streptomycin. To establish cell lines stably
expressing MKRN1, the MKRN1-V5 construct was transfected into
HT1080 cells using Lipofectamine Plus according to the manufacturer’s
instructions (Invitrogen). Multiple independent single clones were isolated and checked for protein expression by immunoblotting with antiV5 antibody.
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Expression vectors
The Flag-hTERT expression vector was constructed by cloning the fulllength hTERT cDNA into a pCMV-Tag2 vector (Stratagene). The hTERTHA expression vector has been described (Seimiya et al. 2000). The HAubiquitin expression vector was constructed by cloning the BamHI and
XbaI fragment encoding the ubiqutin cDNA into pcDNA3.1 (Invitrogen)
(J.S. Lee et al. 2004). The MKRN1-V5 expression vector was constructed
by inserting the EcoRI and NotI fragment from the full-length MKRN1
cDNA into pcDNA3.1/V5. The expression vector for GST-hTERT-HA
was constructed by cloning the fragment encoding the C-terminal region
(amino acids 946–1132) of hTERT into pGEX-5X-2 (Amersham Biosciences). MKRN1 and its mutants were subcloned into pGEX-6P-1 for expression in bacteria.
Yeast two-hybrid screening
Yeast two-hybrid screening was performed as described (G.E. Lee et al.
2004). Briefly, the yeast strain EGY48 harboring pLexA-hTERT (amino
acids 946–1132) and pSH18-34 was transformed by the lithium acetate
method with a HeLa cDNA library fused to the activation domain vector
pB42AD (Clontech).
Immunoprecipitation and immunoblotting
H1299 cells were transiently transfected with the expression vectors as
indicated using TransFast transfection reagent (Promega). Cells were
lysed with buffer containing 0.5% NP-40, 50 mM Tris-HCl (pH 7.5), 150
mM NaCl, and 2 mM phenyl methylsulphonyl fluoride. After centrifugation at 12,000 rpm for 30 min, the supernatants were immunoprecipitated for 2 h with anti-Flag (Sigma) or anti-HA (Santa Cruz biotechnology) antibodies and then incubated with Sepharose beads conjugated to
Protein G (Amersham Biosciences). When ubiquitin conjugates of
hTERT were detected, immunoprecipitation was performed with lysis
buffer containing 0.1% SDS to dissociate its interacting proteins. Immunoblot analyses were performed using anti-hTERT (Santa Cruz biotechnology), anti-V5 (Invitrogen), anti-HA, and anti-Flag antibodies.
In vitro ubiquitination assay
GST-hTERT-HA expressed in bacteria was used as substrate for in vitro
ubiquitination assay as previously described (Park et al. 2004). Purified
wild-type or mutant MKRN1 as an E3 enzyme was added to the ubiquitination reaction as indicated. The reaction mixtures were incubated at
30°C for 60 min and terminated with sample loading buffer and run on
SDS-PAGE. Slow migrating ubiquitin conjugates were visualized by immunoblot analysis with anti-HA antibody.
Telomerase assays
The telomeric repeat amplification protocol (TRAP) was used as previously described (Kim et al. 2003). Cell extracts (200 ng of protein) were
added to telomerase extension reactions and incubated for 20 min at
37°C. PCR was performed using the TS primer and ACX primer for 30
cycles (denaturation at 94°C for 30 sec, annealing at 60°C for 30 sec, and
extension at 72°C for 30 sec). As an internal telomerase assay standard,
NT and TSNT primers were added to the PCR mixture as previously
described (Kim and Wu 1997). Telomerase products were resolved by
electrophoresis on a 12% nondenaturing polyacrylamide gel. Bands were
then visualized by staining with SYBR Green (Molecular Probes). The
signal intensity was quantified with a LAS-1000 Plus Image analyzer
(Fuji Photo Film).
Terminal restriction fragment (TRF) analysis
To measure the telomere length, genomic DNA was digested with RsaI
and HinfI and separated on a 0.7% agarose gel. DNA samples were transferred to a nylon membrane (Hybond N+; Amersham Biosciences) and
hybridized with a 32P-labeled probe (TTAGGG)20. Signals were detected
by a phosphoimage analyzer (Fuji Photo Film).
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